Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial

Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page footer revision label changed from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:41:04.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added to the history; prior notices about funding and operating status (v3.4.1) remain in earlier versions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T13:57:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding was added, informing users that information may not be up to date and the NIH Clinical Center is open; the page revision history now shows Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:38:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history page now shows a glossary toggle, color-coded additions/deletions, and a revision label (v3.4.0). The No FEAR Act data note and the older revision label (v3.3.4) were removed.
    Difference
    0.6%
    Check dated 2026-01-28T06:35:26.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the history and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:57:02.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The new page footer shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure as well as Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:18:49.000Z thumbnail image

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.